BioSpace News Archive

BioMidwest

DiaMedica Letter to Shareholders

The company provides a corporate update. in the letter.

January 18, 2018
·
6 min read
Policy

MiMedx Comments on Magistrate Recommendation in the Company’s Lawsuit Against Short Sellers

The Company believes that the Magistrate’s recommendations are in error, and therefore MiMedx will be filing objections with the District Court Judge.

January 18, 2018
·
4 min read
Drug Development

AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency

The primary objective of this Phase II study is to investigate the safety of escalating doses of MS1819-SD in patients with CP.

January 18, 2018
·
5 min read
Bio NC

Argos Announces One-for-Twenty Reverse Stock Split

The Board of Directors approved a one-for-twenty reverse split of the Company’s common stock that will take effect today, January 18, 2018 after the close of trading.

January 18, 2018
·
5 min read
Drug Development

Caladrius Biosciences Announces Completion of Enrollment of Phase II T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

Primary endpoint topline data to be reported in early 2019.

January 18, 2018
·
5 min read
Pharm Country

Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV (levoketoconazole) for the Treatment of Cushing’s Syndrome

The claims of the U.S. patent application are directed towards methods of treating Cushing’s syndrome with levoketoconazole.

January 18, 2018
·
5 min read
Business

Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development

Mr. Sullivan brings over 25 years of global pharmaceutical and vaccine experience with Merck & Co, Inc. to his new position at Immunovaccine.

January 18, 2018
·
4 min read
Drug Development

Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients With Bacterial Vaginosis

Radezolid is also being studied by Melinta’s partner in a Phase 2 clinical study for the treatment of mild-to-moderate acne vulgaris.

January 18, 2018
·
7 min read
BioCapital

Diffusion Pharmaceuticals Announces $12M Underwritten Public Offering

H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.

January 18, 2018
·
6 min read
Business

Sandoz Announces Exclusive Global Collaboration With Biocon on Next-Generation Biosimilars

Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products, and will have a cost and profit share arrangement globally.

January 18, 2018
·
6 min read